Global Effervescent Tablet Market Current Trends, Growth Opportunities, Business Insights (2024-2033)

Overview and Scope

Effervescent tablets are the solid dosage form of tablets that are engineered to break down faster when they come into contact with water by releasing carbon dioxide. The tablets entirely disintegrate in a matter of minutes, releasing the medication into solution.

Sizing and Forecast

The effervescent tablet market size has grown strongly in recent years. It will grow from $33.49 billion in 2023 to $36.82 billion in 2024 at a compound annual growth rate (CAGR) of 10.0%.  The  growth in the historic period can be attributed to early pharmaceutical innovations, medical advancements, emergence of consumer health trends, consumer convenience and preference, marketing and branding strategies..

The effervescent tablet market size is expected to see rapid growth in the next few years. It will grow to $54.94 billion in 2028 at a compound annual growth rate (CAGR) of 10.5%.  The growth in the forecast period can be attributed to preference for convenient dosage forms, innovation in formulations, consumer demand for novelty, healthcare professional endorsements, demographic shifts.. Major trends in the forecast period include market value structure, cost drivers, growth rate, sales channels, technological advancements.

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/effervescent-tablet-global-market-report

Segmentation & Regional Insights

The effervescent tablet market covered in this report is segmented –

1) By Product: Medication, Supplements

2) By Methods: Dry Methods, Wet Granulation

3) By Indication: Diuretics, Pain Management, Gastric Disorders, Respiratory Diseases, Other Indications

4) By Application: Dental Products, Dietary Supplements, Pharmaceutical, Other Applications

5) By End-User: Hospitals, Specialty Clinics, Homecare, Other End-Users

Top Major Players:
Bayer AG
Hermes Arzneimittel GmbH
GlaxoSmithKline PLC
Reckitt Benckiser Group PLC
Bristol-Myers Squibb Company
Bliss GVS Pharma Limited

North America was the largest region in the effervescent tablets market share in 2023.

North America was the largest region in the effervescent tablets market share in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the effervescent tablet market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8295&type=smp

Major Driver Impacting Market Growth

 The high prevalence rate of chronic diseases is expected to propel the growth of the effervescent tablets market going forward. Chronic disease often lasts for three months or longer and may worsen with time. The most prevalent chronic diseases are cancer, heart disease, stroke, diabetes, and arthritis. Effervescent tablets are used in the treatment of chronic illnesses such as diabetes, cancer, and heart disease as a potent antioxidant that boosts blood antioxidant levels and helps reduce the risk of chronic diseases. For instance, in January 2022, according to research published by the American Cancer Society, a US-based health organization, in the US, 609,360 cancer deaths and 1.9 million new cancer cases are anticipated in 2022. It is about 1,670 fatalities each day. Therefore, the high prevalence rate of chronic diseases is driving the growth of the effervescent tablets market.

Key Industry Players

 Major companies operating in the effervescent tablet market report are Bayer AG, Hermes Arzneimittel GmbH, GlaxoSmithKline plc, Reckitt Benckiser Group plc, Bristol-Myers Squibb Company, Bliss GVS Pharma Limited, Herbalife International Inc., Amerilab Technologies Inc., Pfizer Inc., Novartis AG, Perrigo Company plc, Chiesi Farmaceutici SpA, SG Biopharm Pvt. Ltd., Advanced Enzyme Technologies Limited, Vovantis Laboratories Pvt. Ltd., Nutrilo GmbH, Tower Laboratories Ltd., Losan Pharma GmbH, American Health, BioVit GMP Laboratories Limited, By-health Co. Ltd., Vitabiotics Ltd., Prestige Brands Inc., Nuun and Company Inc., DMK Group, Amway Corp, GNC Holdings Inc., Sanofi SA, Merck KGaA, Roche Holding AG, Johnson & Johnson, Procter & Gamble Co., Unilever plc, Nestle SA, PepsiCo Inc., The Coca-Cola Company, Dr Reddy’s Laboratories Ltd.

The effervescent tablet market report table of contents includes:

1. Executive Summary
2. Effervescent Tablet Market Characteristics
3. Effervescent Tablet Market Trends And Strategies
4. Effervescent Tablet Market – Macro Economic Scenario
5. Global Effervescent Tablet Market Size and Growth
…
31. Global Effervescent Tablet Market Competitive Benchmarking
32. Global Effervescent Tablet Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Effervescent Tablet Market
34.Effervescent Tablet Market Future Outlook and Potential Analysis
35. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model